2023 Q1 Form 10-K Financial Statement
#000121390023023683 Filed on March 28, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $2.821M | $3.230M | $11.43M |
YoY Change | |||
Cost Of Revenue | $2.932M | $3.640M | $11.86M |
YoY Change | 54.4% | 73.19% | |
Gross Profit | -$111.5K | -$420.0K | -$428.9K |
YoY Change | -94.13% | -93.74% | |
Gross Profit Margin | -3.95% | -13.0% | -3.75% |
Selling, General & Admin | $5.210M | $6.280M | $13.56M |
YoY Change | 25032.66% | 8482.75% | 13850.62% |
% of Gross Profit | |||
Research & Development | $227.0K | $280.0K | $2.377M |
YoY Change | -82.09% | -32.74% | |
% of Gross Profit | |||
Depreciation & Amortization | $273.1K | $150.0K | $516.9K |
YoY Change | 145.33% | 41.59% | |
% of Gross Profit | |||
Operating Expenses | $227.0K | $6.710M | $2.377M |
YoY Change | -52.65% | 682.31% | 83.04% |
Operating Profit | -$5.824M | -$7.130M | -$18.38M |
YoY Change | 116.68% | 181.9% | |
Interest Expense | -$4.930M | -$660.0K | -$3.710M |
YoY Change | -302.79% | -114.04% | -442.51% |
% of Operating Profit | |||
Other Income/Expense, Net | -$4.356M | -$440.0K | $9.881M |
YoY Change | 433.78% | -2700.05% | |
Pretax Income | -$14.14M | -$8.220M | -$28.26M |
YoY Change | -824.51% | -313.88% | 4646.07% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$10.18M | -$8.223M | -$28.26M |
YoY Change | -621.61% | -313.96% | 4646.17% |
Net Earnings / Revenue | -360.89% | -254.59% | -247.14% |
Basic Earnings Per Share | -$0.26 | -$1.75 | |
Diluted Earnings Per Share | -$0.26 | -$0.21 | -$1.75 |
COMMON SHARES | |||
Basic Shares Outstanding | 47.28M shares | 47.25M shares | 18.98M shares |
Diluted Shares Outstanding | 39.77M shares | 18.98M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $12.50M | $22.70M | $22.70M |
YoY Change | 4117.56% | -87.01% | 4274.55% |
Cash & Equivalents | $12.48M | $17.79M | $17.80M |
Short-Term Investments | $0.00 | $5.000M | $5.000M |
Other Short-Term Assets | $54.38K | $2.710M | $5.300M |
YoY Change | 20.88% | 3568.65% | 7074.77% |
Inventory | $11.01M | $6.667M | $6.700M |
Prepaid Expenses | $5.393M | $2.393M | |
Receivables | $2.635M | $1.622M | $2.200M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $32.15M | $36.96M | $37.00M |
YoY Change | 9317.31% | 6135.65% | 6141.88% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $16.95M | $15.17M | $15.50M |
YoY Change | 955.26% | ||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $140.2K | $155.5K | $200.0K |
YoY Change | -99.92% | -99.91% | -99.89% |
Total Long-Term Assets | $17.35M | $15.64M | $15.60M |
YoY Change | -90.04% | -91.02% | -91.05% |
TOTAL ASSETS | |||
Total Short-Term Assets | $32.15M | $36.96M | $37.00M |
Total Long-Term Assets | $17.35M | $15.64M | $15.60M |
Total Assets | $49.49M | $52.60M | $52.60M |
YoY Change | -71.65% | -69.91% | -69.91% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.607M | $324.5K | $300.0K |
YoY Change | 1362.33% | 111.25% | 95.31% |
Accrued Expenses | $3.656M | $3.143M | $3.600M |
YoY Change | 3860.0% | 10554.16% | 4246.25% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $6.611M | $3.878M | $3.900M |
YoY Change | 1077.18% | 1062.24% | 1068.96% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $16.83M | $15.92M | $15.90M |
YoY Change | |||
Other Long-Term Liabilities | $34.93M | $32.80M | |
YoY Change | 528.18% | 311.38% | |
Total Long-Term Liabilities | $51.76M | $15.92M | $48.70M |
YoY Change | 830.89% | 99.69% | 510.79% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.611M | $3.878M | $3.900M |
Total Long-Term Liabilities | $51.76M | $15.92M | $48.70M |
Total Liabilities | $58.37M | $52.58M | $52.60M |
YoY Change | 853.59% | 532.91% | 533.21% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$78.29M | -$68.11M | |
YoY Change | 783.44% | ||
Common Stock | $4.728K | $454.4K | |
YoY Change | 105317.87% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$8.878M | $27.82K | $0.00 |
YoY Change | |||
Total Liabilities & Shareholders Equity | $49.49M | $52.60M | $52.60M |
YoY Change | -71.65% | -69.91% | -69.91% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$10.18M | -$8.223M | -$28.26M |
YoY Change | -621.61% | -313.96% | 4646.17% |
Depreciation, Depletion And Amortization | $273.1K | $150.0K | $516.9K |
YoY Change | 145.33% | 41.59% | |
Cash From Operating Activities | -$8.833M | -$5.740M | -$37.27M |
YoY Change | 1704.46% | 2025.14% | 3484.79% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $3.470M | -$12.40M | -$19.21M |
YoY Change | -88.97% | ||
Cash From Investing Activities | $3.465M | -$12.40M | -$19.21M |
YoY Change | -306.85% | -88.98% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $31.00M | ||
YoY Change | 744.15% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $59.19K | 0.000 | $53.32M |
YoY Change | -77.83% | -69.67% | |
NET CHANGE | |||
Cash From Operating Activities | -$8.833M | -5.740M | -$37.27M |
Cash From Investing Activities | $3.465M | -12.40M | -$19.21M |
Cash From Financing Activities | $59.19K | 0.000 | $53.32M |
Net Change In Cash | -$5.309M | -18.14M | -$3.166M |
YoY Change | 2285.73% | 6616.03% | -740.95% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$8.833M | -$5.740M | -$37.27M |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-40611 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
NAUTICUS ROBOTICS, INC. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
85-1699753 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
17146 FEATHERCRAFT LANE | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
SUITE 450 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
WEBSTER | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
77598 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
(281) | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
942-9069 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value per share, and one-half of one redeemable warrant | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
KITT | |
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
Yes | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
true | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
173707500 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
47281275 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
726 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Whitley Penn LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Houston, Texas | |
CY2022Q4 | us-gaap |
Cash
Cash
|
17787159 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
20952867 | usd |
CY2022Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
250375 | usd |
CY2021Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
251236 | usd |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
4959263 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1622434 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
794136 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
6666912 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
|
573895 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
|
893375 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2392978 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
67219 | usd |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2710031 | usd |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
210225 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
36963047 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
23169058 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
15167367 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1437311 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
317208 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
513763 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
155490 | usd |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
47240 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
52603112 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
25167372 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
324484 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1402424 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3142977 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1576433 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
410158 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
353598 | usd |
CY2021Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
10250000 | usd |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
3000000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3877619 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
16582455 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
32688342 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
87214 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
467208 | usd |
CY2022Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
15922118 | usd |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
14708333 | usd |
CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
20833 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
52575293 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
31778829 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2021Q4 | kitt |
Preferred Stock Value1
PreferredStockValue1
|
3348 | usd |
CY2021Q4 | kitt |
Preferred Stock Value2
PreferredStockValue2
|
7254 | usd |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
625000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
625000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47250771 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9669217 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47250771 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9669217 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4725 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
967 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
68128196 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
33221505 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-68105102 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-39844531 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27819 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6611457 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
52603112 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
25167372 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
11434959 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
8591540 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
11863862 | usd |
CY2021 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
6850248 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
516949 | usd |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
365097 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2376912 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3533713 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
15056565 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4362400 | usd |
CY2022 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
29814288 | usd |
CY2021 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
15111458 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18379329 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6519918 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-293862 | usd |
CY2021 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1601568 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
9484113 | usd |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-6461087 | usd |
CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
3714017 | usd |
CY2021 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
725166 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
9881242 | usd |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
8607711 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28260571 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15127629 | usd |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.75 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.57 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
18982139 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9637962 | shares |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1428721 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
107794 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1519682 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2840609 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
100570 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1074911 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3814950 | usd |
CY2021Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
117571 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1298122 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4995501 | usd |
CY2021Q4 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
99645 | usd |
CY2021Q4 | kitt |
Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
|
9484113 | usd |
CY2021Q4 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
35200 | usd |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11234914 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6611457 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
200157 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3504002 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9915302 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
188657 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3356956 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13083601 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
14548914 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
-669242 | usd |
CY2022Q3 | kitt |
Issuance Of Common Stock For Pipe Investment
IssuanceOfCommonStockForPIPEInvestment
|
31000000 | usd |
CY2022Q3 | kitt |
Equity Issuance Costs
EquityIssuanceCosts
|
-12582000 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
235593 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13176497 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6273167 | usd |
CY2022Q4 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1977768 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8223116 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27819 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28260571 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15127629 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
516949 | usd |
CY2021 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
365097 | usd |
CY2022 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1342062 | usd |
CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
29166 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2602175 | usd |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
425580 | usd |
CY2021 | us-gaap |
Extinguishment Of Debt Gain Loss Income Tax
ExtinguishmentOfDebtGainLossIncomeTax
|
9484113 | usd |
CY2022 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
6461087 | usd |
CY2022 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
196555 | usd |
CY2021 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
205966 | usd |
CY2021 | us-gaap |
Other Income
OtherIncome
|
1578500 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
828298 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
721401 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6666912 | usd |
CY2022 | us-gaap |
Increase Decrease In Commodity Contract Assets And Liabilities
IncreaseDecreaseInCommodityContractAssetsAndLiabilities
|
-319480 | usd |
CY2021 | us-gaap |
Increase Decrease In Commodity Contract Assets And Liabilities
IncreaseDecreaseInCommodityContractAssetsAndLiabilities
|
831489 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
4902797 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
275759 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-7731279 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2287134 | usd |
CY2021 | us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
-1433370 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
323434 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
330598 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-37274983 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7501690 | usd |
CY2022 | us-gaap |
Payments For Capital Improvements
PaymentsForCapitalImprovements
|
14247005 | usd |
CY2021 | us-gaap |
Payments For Capital Improvements
PaymentsForCapitalImprovements
|
922487 | usd |
CY2022 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
4959263 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-19206268 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-922487 | usd |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
2000000 | usd |
CY2021 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
24950000 | usd |
CY2021 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1578500 | usd |
CY2021 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
35200 | usd |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
17850333 | usd |
CY2021 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
484836 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3298180 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17787159 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
20952867 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2719947 | usd |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
25909 | usd |
CY2022 | kitt |
Conversion Of Convertible Debt And Accrued Interest Expense To Common Stock
ConversionOfConvertibleDebtAndAccruedInterestExpenseToCommonStock
|
14548914 | usd |
CY2022 | kitt |
Proceeds From Reverse Recapitalization With Cleantech Acquisition Corp Net
ProceedsFromReverseRecapitalizationWithCleantechAcquisitionCorpNet
|
14947876 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
31000000 | usd |
CY2022 | us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
35800000 | usd |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
12582000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
53315543 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
26078864 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3165708 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
17654687 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
20952867 | usd |
CY2022 | kitt |
Conversion Of Series A Preferred Stock In Connection With Reverse Recapitalization
ConversionOfSeriesAPreferredStockInConnectionWithReverseRecapitalization
|
3348 | usd |
CY2022 | kitt |
Conversion Of Series B Preferred Stock In Connections With Reverse Recapitalizationin Shares
ConversionOfSeriesBPreferredStockInConnectionsWithReverseRecapitalizationinShares
|
7254 | usd |
CY2022 | kitt |
Private And Public Warrant Liabilities Assumed In Reverse Recapitalization
PrivateAndPublicWarrantLiabilitiesAssumedInReverseRecapitalization
|
5278145 | usd |
CY2022 | kitt |
Fair Value Of Spa Warrants At Issuance
FairValueOfSPAWarrantsAtIssuance
|
20949110 | usd |
CY2021 | kitt |
Loan Commitment Fee
LoanCommitmentFee
|
-300000 | usd |
CY2022 | kitt |
Shares Issued Description
SharesIssuedDescription
|
follows (i) an aggregate of 36,650,778 shares of Common Stock, par value $0.0001 (the “Common Stock” of CLAQ prior to the Closing, and the Common Stock of Nauticus following the Closing) shares were issued to holders of Nauticus Common Stock in the Business Combination (ii) the right to receive 7,499,993 additional shares of Common Stock held in escrow pursuant to the terms of the Merger Agreement and as further described below (such additional escrowed shares, the “Earnout Shares”) and (iii) the issuance of 3,100,000 shares of Common Stock for the Equity Financing (as described below). An aggregate of 47,250,771 shares of Common Stock (inclusive of the Earnout Shares) was issued after the Business Combination. | |
CY2022Q4 | kitt |
Additional Share Of Common Stock
AdditionalShareOfCommonStock
|
7499993 | shares |
CY2022 | us-gaap |
Intercompany Agreements Description
IntercompanyAgreementsDescription
|
i.one-half of the Earnout Shares will be released if, within a 5-year period, the volume-weighted average price of our Common Stock equals or exceeds $15.00 per share over any 20 trading days within a 30-day trading period; ii.one-quarter of the Earnout Shares will be released if, within a 5-year period, the volume-weighted average price of our Common Stock equals or exceeds $17.50 per share over any 20 trading days within a 30-day trading period; and iii.one-quarter of the Earnout Shares will be released if, within a 5-year period, the volume-weighted average price of our Common Stock equals or exceeds $20.00 per share over any 20 trading days within a 30-day trading period. | |
CY2022Q4 | us-gaap |
Excess Stock Shares Issued
ExcessStockSharesIssued
|
3100000 | shares |
CY2022 | us-gaap |
Common Stock Convertible Conversion Price Decrease
CommonStockConvertibleConversionPriceDecrease
|
10 | |
CY2022 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
31000000 | usd |
CY2022Q4 | us-gaap |
Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
|
36530320 | usd |
CY2022Q3 | us-gaap |
Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
|
14947875 | usd |
CY2022Q3 | us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
30157 | usd |
CY2022Q3 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
14796942 | usd |
CY2022Q3 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
850333 | usd |
CY2022Q3 | us-gaap |
Temporary Equity Net Income
TemporaryEquityNetIncome
|
-669243 | usd |
CY2022Q4 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
14947875 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
12582000 | usd |
CY2022Q4 | kitt |
Nonrefundable Deposit
NonrefundableDeposit
|
5420000 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) estimates of future costs to complete customer contracts recognized over time, (ii) valuation allowances for deferred income tax assets, (iii) valuation of stock-based compensation awards and (iv) the valuation of conversion options, warrants and earnouts. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
250000 | usd |
CY2021Q4 | us-gaap |
Compensated Absences Liability
CompensatedAbsencesLiability
|
349255 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
794021 | usd |
CY2022Q4 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
590936 | usd |
CY2021Q4 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
61752 | usd |
CY2021Q4 | us-gaap |
Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
|
703544 | usd |
CY2021Q4 | kitt |
Advance Customer Payments
AdvanceCustomerPayments
|
373791 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
|
1499030 | usd |
CY2022Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
5167882 | usd |
CY2022Q4 | us-gaap |
Inventory Gross
InventoryGross
|
6666912 | usd |
CY2022 | kitt |
Recognized Income Tax
RecognizedIncomeTax
|
0.50 | pure |
CY2022 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
9705 | usd |
CY2021 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
0 | usd |
CY2022 | us-gaap |
Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
|
261000 | usd |
CY2021 | us-gaap |
Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
|
470 | usd |
CY2022 | us-gaap |
Interest Paid
InterestPaid
|
804000 | usd |
CY2022 | kitt |
Total Balance Percentage
TotalBalancePercentage
|
0.95 | pure |
CY2021 | kitt |
Total Balance Percentage
TotalBalancePercentage
|
0.89 | pure |
CY2022 | kitt |
Customer Percentage
CustomerPercentage
|
0.10 | pure |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2710031 | usd |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
210225 | usd |
CY2022Q4 | us-gaap |
Compensated Absences Liability
CompensatedAbsencesLiability
|
1501736 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
256284 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
88091 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
3142977 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
1576433 | usd |
CY2022 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Reclassifications</i> – Financial statements presented for prior periods include reclassifications that were made to conform to the current-period presentation. There was no material impact to the consolidated financial statements for these changes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> | |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Accounting Pronouncements – </i>In June 2016, the FASB issued ASU 2016-13, <i>Financial Instruments—Credit Losses</i>, which replaces the existing incurred loss impairment model with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. We adopted this standard on January 1, 2022. There was no impact from the adoption of this standard on our consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no other new accounting pronouncements that are expected to have a material impact on our consolidated financial statements.</p> | |
CY2022 | us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
11434959 | usd |
CY2021 | us-gaap |
Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
|
8591540 | usd |
CY2021Q2 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
126111 | usd |
CY2022 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
1513333 | usd |
CY2021 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
756667 | usd |
CY2022 | us-gaap |
Accounts Receivable Purchase
AccountsReceivablePurchase
|
1622434 | usd |
CY2021 | us-gaap |
Accounts Receivable Purchase
AccountsReceivablePurchase
|
794136 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
|
9963 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
|
0 | usd |
CY2022 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
9963 | usd |
CY2021 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
0 | usd |
CY2022 | us-gaap |
Contract With Customer Asset Sale
ContractWithCustomerAssetSale
|
319480 | usd |
CY2021Q4 | kitt |
Contract Liabilities
ContractLiabilities
|
306791 | usd |
CY2021 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
67000 | usd |
CY2021 | kitt |
Revenue Recognize
RevenueRecognize
|
11100000 | usd |
CY2022Q4 | kitt |
Contract Receivable Retainages Due One To Two Years
ContractReceivableRetainagesDueOneToTwoYears
|
11.1 | usd |
CY2022Q4 | kitt |
Contract Receivable Retainages Due Two To Three Years
ContractReceivableRetainagesDueTwoToThreeYears
|
7 | usd |
CY2022Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
4.1 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2003341 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1492892 | usd |
CY2022Q4 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
12974361 | usd |
CY2021Q4 | us-gaap |
Construction In Progress Gross
ConstructionInProgressGross
|
150220 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
15167367 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
1437311 | usd |
CY2022 | kitt |
Convertible Secured Debentures
ConvertibleSecuredDebentures
|
36530320 | usd |
CY2021Q4 | us-gaap |
Long Term Construction Loan Current
LongTermConstructionLoanCurrent
|
14708333 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
36530320 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
27958333 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
-20608202 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
13250000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
15922118 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
14708333 | usd |
CY2022 | kitt |
Business Combination Description
BusinessCombinationDescription
|
(i) an aggregate of 5,299,546 shares of Common Stock and (ii) a pro-rata number of the total Earnout Shares in the Business Combination | |
CY2022Q4 | us-gaap |
Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
|
36530320 | usd |
CY2022 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
2922425 | shares |
CY2022 | kitt |
Inclusive Proceeds
InclusiveProceeds
|
35800000 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.02 | pure |
CY2022 | kitt |
Fair Value Debenture Warrants
FairValueDebentureWarrants
|
20949110 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
21679716 | usd |
CY2022 | kitt |
The Debentures Converted Description
TheDebenturesConvertedDescription
|
The Debentures may be converted at the holders’ option at 120% of the principal amount at a conversion price of $15.00 or 2,922,425 shares of Common Stock. The conversion price may be adjusted downward for certain events including the issuance by the Company of dilutive instruments below the current conversion price. Interest accrues on the outstanding principal amount of the Debentures at 5% per annum, payable quarterly. | |
CY2022 | kitt |
Exercisable Initially Par Share
ExercisableInitiallyParShare
|
20 | |
CY2022 | us-gaap |
Interest Income Debt Securities Trading Operating
InterestIncomeDebtSecuritiesTradingOperating
|
1071228 | usd |
CY2022 | us-gaap |
Debt Instrument Interest Rate Basis For Effective Rate
DebtInstrumentInterestRateBasisForEffectiveRate
|
25.2% | |
CY2021Q4 | kitt |
Term Loan Credit Agreement
TermLoanCreditAgreement
|
we entered into a Term Loan Credit Agreement with RCB Equities #1, LLC (“RCB”) in the amount of $15,000,000 to provide funds for the Company’s working capital and general corporate purposes. The note bore interest at 13% per annum and was payable in 18 monthly installments of interest only through its maturity date of June 16, 2023. A 2% commitment fee totaling $300,000 was paid upon loan inception and reported as a debt discount. There was also a 5% exit fee, accrued over the note term, totaling $750,000. | |
CY2022Q3 | kitt |
Additional Borrowing
AdditionalBorrowing
|
2000000 | usd |
CY2022Q3 | us-gaap |
Debt Instrument Fee
DebtInstrumentFee
|
$33,000 | |
CY2022Q3 | us-gaap |
Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
|
100000 | usd |
CY2022 | kitt |
Matures Date
MaturesDate
|
2024-04-30 | |
CY2022 | kitt |
Discount Interest Rate
DiscountInterestRate
|
0.08 | pure |
CY2022Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.08 | pure |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
56634 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
96375 | usd |
CY2022 | us-gaap |
Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
|
359615 | usd |
CY2021 | us-gaap |
Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
|
360780 | usd |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P16Y | |
CY2022 | kitt |
Right Of Use Asset Lease Liability Percentage
RightOfUseAssetLeaseLiabilityPercentage
|
0.0775 | pure |
CY2022 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
3475 | usd |
CY2022Q4 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P31Y | |
CY2022Q4 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.08 | pure |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
275763 | usd |
CY2021 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
275485 | usd |
CY2022 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
178032 | usd |
CY2021 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
180818 | usd |
CY2022 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
453795 | usd |
CY2021 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
456303 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
409347 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
142847 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
4865 | usd |
CY2022Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
557059 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2022 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-28260571 | usd |
CY2021 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-15127629 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-5934720 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-3176802 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
193421 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
1754071 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
5741299 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
1422731 | usd |
CY2022 | kitt |
Effective Tax Rate
EffectiveTaxRate
|
0 | pure |
CY2021 | kitt |
Effective Tax Rate
EffectiveTaxRate
|
0 | pure |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Regulatory Assets
DeferredTaxLiabilitiesRegulatoryAssets
|
113135 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Regulatory Assets
DeferredTaxLiabilitiesRegulatoryAssets
|
103863 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
758306 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
211849 | usd |
CY2022 | us-gaap |
Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
|
1356828 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
9666591 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6262113 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
1426116 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
1426117 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
449626 | usd |
CY2022Q4 | us-gaap |
Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
|
109616 | usd |
CY2021Q4 | us-gaap |
Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
|
13634 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
13880218 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
8017576 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
|
54729 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
66614 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
121343 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13758875 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
8017576 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
|
46300000 | usd |
CY2022 | kitt |
Expired Amount
ExpiredAmount
|
646000 | usd |
CY2022Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
6619490 | shares |
CY2022Q4 | us-gaap |
Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
|
950000 | shares |
CY2022Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
3100000 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10 | |
CY2022Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
31000000 | usd |
CY2022Q4 | us-gaap |
Shares Issued
SharesIssued
|
7499993 | shares |
CY2022 | us-gaap |
Assets Fair Value Adjustment
AssetsFairValueAdjustment
|
4957366 | usd |
CY2022 | kitt |
Private Warrants Shares
PrivateWarrantsShares
|
8625000 | shares |
CY2022 | us-gaap |
Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
|
0.01 | |
CY2022 | kitt |
Common Stock Exceeds Price
CommonStockExceedsPrice
|
16.5 | |
CY2022 | us-gaap |
Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
|
11.5 | |
CY2022Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
1934588 | usd |
CY2022 | kitt |
Private Warrants Description
PrivateWarrantsDescription
|
The fair value of the Private Warrants was estimated using a Black-Scholes option pricing model using the following assumptions: stock price of $3.74, no assumed dividends, a risk-free rate of 4.03% and implied volatility of 36.9%. The change in value of the Private Warrants during the year ended December 31, 2022 totaled $(497,307) and was reported with other (income) expense in our consolidated statements of operations. | |
CY2022 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
7528508 | usd |
CY2022 | us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
4589977 | shares |
CY2022 | kitt |
Business Combination Shares
BusinessCombinationShares
|
279464 | shares |
CY2022 | us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
3970266 | shares |
CY2022 | kitt |
Continuous Service Percentage
ContinuousServicePercentage
|
0.25 | pure |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1422492 | usd |
CY2022 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
|
P2Y6M21D | |
CY2022 | us-gaap |
Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
|
14.2069 | pure |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | usd |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
42944 | usd |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
|
6554541 | usd |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
|
2992895 | usd |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
4278240 | usd |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1678662 | usd |
CY2022 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
784530 | usd |
CY2021 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
425580 | usd |
CY2022 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Tax Benefit
ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit
|
0 | usd |
CY2021 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Tax Benefit
ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit
|
16410 | usd |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y | |
CY2022 | kitt |
Vested Percentage
VestedPercentage
|
0.50 | pure |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
0 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
3149800 | shares |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
4.73 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
15123 | shares |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
|
4.73 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
3134677 | shares |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
4.73 | |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
|
11723692 | usd |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P1Y7M6D | |
CY2022 | kitt |
Employees Gross Salaries Percentage
EmployeesGrossSalariesPercentage
|
0.03 | pure |
CY2022 | us-gaap |
Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1
PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1
|
367796 | usd |
CY2021 | us-gaap |
Prescription Drug Benefit Effect Of Subsidy On Net Periodic Postretirement Benefit Cost1
PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1
|
210945 | usd |
CY2022Q3 | us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
224400 | usd |
us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
494835 | usd | |
CY2021Q3 | us-gaap |
Accounts Receivable Related Parties
AccountsReceivableRelatedParties
|
21000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Related Parties
AccountsReceivableRelatedParties
|
39225 | usd |
kitt |
Investment And Securities Description
InvestmentAndSecuritiesDescription
|
(i) $2,500,000 from related party Material Impact Fund II, L.P. as their contribution to the PIPE Investment, (ii) $7,500,000 from related party Schlumberger Technology Corporation as their contribution to the PIPE Investment, (iii) $7,500,000 from related party Transocean Ltd. as their contribution to the PIPE Investment, and (iv) $5,102,000 from related party Material Impact Fund II, L.P. pursuant to the Securities Purchase Agreement. Material Impact Fund II,L.P. currently holds $5,102,000 of the outstanding Debentures bearing 5% interest, payable quarterly, maturing September 9, 2026, as well as holding outstanding Common Stock of the Company. | ||
CY2022 | us-gaap |
Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
|
80073 | usd |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
|
-28260571 | usd |
CY2021 | us-gaap |
Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
|
-15127629 | usd |
CY2022 | kitt |
Deemed Dividend For Earnout Shares
DeemedDividendForEarnoutShares
|
-4957366 | shares |
CY2022 | us-gaap |
Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
|
-33217937 | usd |
CY2021 | us-gaap |
Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
|
-15127629 | usd |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
18982139 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9637962 | shares |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.75 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.57 | |
CY2022 | kitt |
Stock Options
StockOptions
|
3506184 | shares |
CY2021 | kitt |
Stock Options
StockOptions
|
3949158 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3134677 | shares |
CY2022 | kitt |
Warrants
Warrants
|
18722425 | shares |
CY2022 | kitt |
Earnout Sharesin Shares
EarnoutSharesinShares
|
7499993 | shares |
CY2022 | kitt |
Debentures Shares
DebenturesShares
|
2922425 | shares |
CY2022 | kitt |
Total Shares
TotalShares
|
35785704 | shares |
CY2021 | kitt |
Total Shares
TotalShares
|
3949158 | shares |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
usd | |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
usd | |
CY2022Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
usd | |
CY2021Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q4 | kitt |
Preferred Stock Value1
PreferredStockValue1
|
usd | |
CY2022Q4 | kitt |
Preferred Stock Value2
PreferredStockValue2
|
usd | |
CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.57 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.75 | |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
CY2022Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
usd | |
CY2022 | us-gaap |
Extinguishment Of Debt Gain Loss Income Tax
ExtinguishmentOfDebtGainLossIncomeTax
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
usd | |
CY2022 | us-gaap |
Other Income
OtherIncome
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
|
usd | |
CY2021 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
usd | |
CY2022 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2022 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
usd | |
CY2021 | kitt |
Proceeds From Reverse Recapitalization With Cleantech Acquisition Corp Net
ProceedsFromReverseRecapitalizationWithCleantechAcquisitionCorpNet
|
usd | |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | |
CY2021 | us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
usd | |
CY2021 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2021 | kitt |
Conversion Of Convertible Debt And Accrued Interest Expense To Common Stock
ConversionOfConvertibleDebtAndAccruedInterestExpenseToCommonStock
|
usd | |
CY2021 | kitt |
Conversion Of Series A Preferred Stock In Connection With Reverse Recapitalization
ConversionOfSeriesAPreferredStockInConnectionWithReverseRecapitalization
|
usd | |
CY2021 | kitt |
Conversion Of Series B Preferred Stock In Connections With Reverse Recapitalizationin Shares
ConversionOfSeriesBPreferredStockInConnectionsWithReverseRecapitalizationinShares
|
usd | |
CY2021 | kitt |
Private And Public Warrant Liabilities Assumed In Reverse Recapitalization
PrivateAndPublicWarrantLiabilitiesAssumedInReverseRecapitalization
|
usd | |
CY2021 | kitt |
Fair Value Of Spa Warrants At Issuance
FairValueOfSPAWarrantsAtIssuance
|
usd | |
CY2022 | kitt |
Loan Commitment Fee
LoanCommitmentFee
|
usd | |
CY2021Q4 | us-gaap |
Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
|
usd | |
CY2021Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
usd | |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
usd | |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
usd | |
CY2021Q4 | us-gaap |
Inventory Gross
InventoryGross
|
usd | |
CY2021 | kitt |
Convertible Secured Debentures
ConvertibleSecuredDebentures
|
usd | |
CY2022Q4 | us-gaap |
Long Term Construction Loan Current
LongTermConstructionLoanCurrent
|
usd | |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
usd | |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
usd | |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | kitt |
Federal Return To Accrual
FederalReturnToAccrual
|
usd | |
CY2021 | kitt |
Federal Return To Accrual
FederalReturnToAccrual
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
shares | |
CY2021 | kitt |
Deemed Dividend For Earnout Shares
DeemedDividendForEarnoutShares
|
shares | |
CY2022 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
18982139 | shares |
CY2021 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
9637962 | shares |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.57 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.75 | |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
shares | |
CY2021 | kitt |
Warrants
Warrants
|
shares | |
CY2021 | kitt |
Earnout Sharesin Shares
EarnoutSharesinShares
|
shares | |
CY2021 | kitt |
Debentures Shares
DebenturesShares
|
shares | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001849820 |